Questcor Launches Acthar for Treatment of Infantile Spasms

Questcor Pharmaceuticals, Inc. Wednesday announced that the commercial launch is now underway for H.P. Acthar Gel (repository corticotropin injection) as monotherapy for the treatment of Infantile Spasms in infants and children under the age of two years.
TheStreet